Table 1.
Disease characteristics at diagnosis | Metastatic disease history and unexpected post-mortem findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient | Age (years) | Race | Type | Subtype | Stage | TNM | Primary to metastatic Dx (months) | Metastatic Dx to death (months) | Primary Dx to death (months) | Clinically Diagnosed Metastatic Organ Involvement | Undiagnosed Findings Post-mortem | Micrometastases Identified by IF |
1 | 46 | Asian | IDC | Low HR / TNBC | IIA | T1N1a | 19 | 10 | 29 | L breast, Skin, Shoulder musculature, Chest wall, L Lung | N/A | N/A |
2 | 31 | Caucasian | IDC | HR+ | IIA | T2N0 | 16 | 31 | 47 | R breast, Lungs, Liver, Adrenals, Bone, Brain | Anterior Chest Mass, Spleen, Ovaries, Dura | Pancreas |
3 | 32 | Caucasian | IDC | HR+ | IIIB | T3N1a | 54 | 86 | 140 | L breast, Anterior chest mass, Thyroid, Lungs, Liver, Bone | Pancreas, Adrenals | N/A |
4 | 47 | Middle Eastern | IDC | HR+ | IIB | T2 N1a | 125 | 163 | 284 | L breast, Chest wall, Liver, Bone, Brain | R Lung, Adrenal | Non-tumor-draining lymph nodes |
5 | 37 | Caucasian | IDC | TNBC | III/IV | T4dN1 | 1 | 12 | 13 | L breast, Skin, Bone | R Breast | Non-tumor-draining lymph nodes |
6 | 67 | Caucasian | IDC | Low HR /TNBC | II | T2N0 | 30 | 30 | 60 | L Breast, Anterior Chest Mass, Chest wall, Lungs, Abdominal mass, Bone, Brain | Liver | N/A |
7 | 58 | Caucasian | Lobular | HR+ | IV | N/A* | De novo metastatic | 35 | 35 | R breast, GI, Bone, Brain, Lung | N/A | N/A |
8 | 69 | Caucasian | IDC | HR+ | I | T3mN0 | 27 | 7 | 34 | L + R breast, Skin, R Lung, Liver, Brain | L Lung, R Adrenal, Kidneys | N/A |
69 | IDC | TNBC | IIa | cT2cN0 | ||||||||
9 | 53 | Asian | IDC | Low HR /TNBC | IIIC | cT2-3N3 | 7 | 6 | 13 | R breast, Liver, Bone, Skin | L Breast, R Chest Wall, L Lung, Adrenals** | Spleen, Bone, Non-tumor-draining lymph nodes |
*De novo metastatic with occult primary ** Not diagnosed but identified on imaging retrospectively; IDC invasive ductal carcinoma, TNBC triple-negative breast cancer, HR hormone receptor, TNM tumor, node, metastasis, L left, R right, GI gastro-intestinal.